Status:
TERMINATED
Impact of Hepatitis C Virus Variability on Steatosis
Lead Sponsor:
University Hospital, Tours
Conditions:
Chronic Hepatitis C
Eligibility:
All Genders
18-75 years
Brief Summary
Chronic infection by the hepatitis C virus (HCV) is a common cause of liver disease, which may progress to cirrhosis and eventually liver cancer. The therapeutic indication will depend mainly on the i...
Eligibility Criteria
Inclusion
- Patients with chronic hepatitis C, naive of an antiviral treatment or after relapse or non-response for an antiviral treatment stopped for more than 1 year
- Liver biopsy necessary for the care of the patient
- Signature of informed consent
Exclusion
- Patients for which the liver biopsy is estimated ≤ 18 mm, so a portion of 3 mm could not be devoted for the study
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00843076
Start Date
January 1 2009
End Date
April 1 2011
Last Update
November 11 2013
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CH de Blois
Blois, France
2
CH de Bourges
Bourges, France
3
CH de Châteauroux
Châteauroux, France
4
CH de Dreux
Dreux, France